Advertisement
Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

B 12/4 - High Blood Sugar Ups COVID Risks

Impact of Medicaid Expansion on Diabetes Outcomes Limited

0

Number of foot exams increased, but no improvements seen in other important care continuum measures

HealthDay Reports: Black Americans Appear Most Vulnerable to Coronavirus

Admission Hyperglycemia Predicts Mortality in COVID-19

0

Patients with hyperglycemia had higher cumulative probability of mortality, independent of preexisting diabetes

Drug-Linked Endogenous Endophthalmitis Hospitalizations Up

Diabetic Retinopathy May Up Risk for COVID-19 Intubation

0

In adjusted analyses, retinopathy independently and significantly associated with more than fivefold higher risk for intubation

New Equation Estimates GFR Across Age Spectrum

Guidelines Developed for Diabetes Management in CKD

0

Recommendations and practice points relate to comprehensive care needs, glycemic monitoring, lifestyle interventions

Major Neurological Disorders on the Rise in the United States

CDC: 26.4 Percent of U.S. Adults With Diabetes Meet ABCS Goals

0

About one in four meet combined goals of management of blood glucose, BP, non-HDL-C, avoiding smoking

Spinal Cord Stimulation May Ease Diabetic Nerve Pain

Spinal Cord Stimulation May Ease Diabetic Nerve Pain

0

Early results of clinical trial show high rate of responders who achieved ≥50 percent pain relief

Telehealth Disparity Seen in Cancer Care

Disparities Seen in Internet Access for Those With Chronic Conditions

0

Internet use lower among those with hypertension and diabetes and among Blacks and Hispanics

For patients with diabetes mellitus and obesity

UEG: Pancreatic CA Down With Bariatric Sx for Obese With DM

0
Prevalence of pancreatic cancer higher in patients with predisposing diabetes and obesity without BS
Women who experience their first myocardial infarction at ≤50 years of age are less likely than men to undergo coronary revascularization or be treated with guideline-directed medical therapies

Outcomes Worse for Women With MI at 50 Years or Younger

0
Women less likely to undergo coronary revascularization, receive guideline-directed medical treatment
Ertugliflozin is noninferior to placebo with respect to major adverse cardiovascular events among patients with type 2 diabetes and atherosclerotic cardiovascular disease

Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD

0
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events